Healthcare & Biotech
-
Paige Unveils Alba AI: Transforming Pathology Research with AI-Driven Efficiency
Paige unveils Alba AI, an advanced assistant that streamlines pathology research by integrating data and automating diagnostic workflows.
-
MyndYou Secures Strategic Investment from WindRose Health
MyndYou, a healthcare AI provider, secured investment from WindRose Health to enhance its AI-driven virtual care assistant, improving patient engagement and clinical efficiency.
-
Noetik Secures $40M Series A Funding to Advance AI-Driven Cancer Therapeutics
Noetik, an AI biotech company, raised $40M in Series A financing to advance cancer research, expand collaborations, and enhance therapeutics.
-
Piramidal Secures $6M in Seed Funding to Advance AI-Powered Neurotech
Piramidal, a San Francisco neurotech startup, secured $6M seed funding for AI-driven brainwave diagnostics with broad medical potential.
-
RevolKa Secures $1.7M Series A Extension to Fuel AI-Driven Protein Engineering
RevolKa, a Tokyo biotech firm, received $1.7M in Series A extension funding, supporting AI-driven drug discovery and rare disease programs.
-
PsychoGenics Secures $3M SBIR Grant to Advance AI-Enabled Drug Discovery
PsychoGenics, a New Jersey biotech firm, was awarded a $3M SBIR Grant to enhance its AI-driven drug discovery platforms.
-
Butlr Secures $38M in Series B Funding to Expand in Senior Care
Butlr, a Burlingame-based physical AI startup, raised $38M in Series B funding to expand its presence in senior care.
-
Slingshot AI Raises $30M in Seed Funding to Advance Mental Health AI
Slingshot AI, a mental health startup, secures $30M seed funding led by Andreessen Horowitz for global expansion and AI development.
-
Piramidal Secures $6M to Enhance AI-Driven Brainwave Analysis for Neurological Diagnoses
Piramidal secures $6 million in funding for its AI-powered brainwave analysis, aiming to improve neurological diagnoses and healthcare innovation.
-
Generative AI Teams Up with Cancer Research: Absci and Memorial Sloan Kettering Collaboration
Absci Corp. and Memorial Sloan Kettering Cancer Center partner for AI-driven cancer therapeutics, pioneering non-profit collaboration in drug discovery.
Eksentricity 